title: Macular fibrosis complicating macular pigment deficient maculopathy in Sjögren-Larsson syndrome.
authors.affiliation: Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands. thomas.theelen@radboudumc.nl.
authors.forename: Thomas
authors.initials: T
authors.lastname: Theelen
authors.affiliation: Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Johannes R M
authors.initials: JR
authors.lastname: Cruysberg
authors.affiliation: Department of Pediatric Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Michèl A A P
authors.initials: MA
authors.lastname: Willemsen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000068258:Bevacizumab / Q000627:therapeutic use; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D005260:Female; D005355:Fibrosis; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D014975:Lutein / Q000172:deficiency*; D008266:Macula Lutea / Q000473:pathology*; D016111:Sjogren-Larsson Syndrome / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D055815:Young Adult; D065146:Zeaxanthins / Q000172:deficiency*
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D065146:Zeaxanthins; D000068258:Bevacizumab; D014975:Lutein